About OKRA
OKRA is a Technology company based in Cambridge (United Kingdom) founded in 2016 by Loubna Bouarfa, and was acquired by Envision Pharma Group in February 2023. It operates in the Technology and Healthcare sectors. OKRA has raised $4.16 million across 1 funding round from investors including Envision Pharma Group. The company has 22 employees. Its chief executive, as recorded, is Loubna Bouarfa. OKRA offers products and services including AI Brain, Commercial Solutions, and Medical Intelligence. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its legal entity is OKRA TECHNOLOGIES LIMITED.
Company details
AI powered platform specializing in healthcare and life sciences. It integrates and analyzes complex datasets from internal, public, and third-party sources to deliver actionable, evidence-based insights and predictions in real time. The platform supports decision-making across the drug development and commercialization lifecycle, helping pharmaceutical and life sciences professionals optimize commercial, medical, and market access strategies.
- Headquarters Cambridge, United Kingdom
- Employees 22
- Founders Loubna Bouarfa
- Stage Acquired
- SectorsTechnologyHealthcare
- Email••••••••
- Phone•••• ••••
- Website okra.ai
- Social LinkedIn X
- Acquired by Envision Pharma Group (Feb 2023)
- Legal Name Okra Technologies Limited
- Date of Incorporation 14 Jul, 2015
- Jurisdiction HORSHAM, WEST SUSSEX, UNITED KINGDOM
- Total Equity Funding$4.16M (USD)
in 1 rounds
- Latest Funding Round$4.16M (USD), Series A
Mar 2018
- Investors
- Employee Count22
- Acquired byEnvision Pharma Group
(Feb 2023)
Products & Services of OKRA
OKRA offers a comprehensive portfolio of products and services, including AI Brain, Commercial Solutions, and Medical Intelligence.
Delivers insights for life sciences decision-making and data analysis.
Optimizes HCP interactions with detailed priority insights.
Analyzes trends and unmet needs in medical affairs.
Funding Insights of OKRA
OKRA has successfully raised a total of $4.16M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.16 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.16M
- Total Rounds 1
- Last Round Series A — $4.16M
- First Round $4.16M
(Mar 2018)
All 1 funding rounds of OKRA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2018 | $4.16M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in OKRA
OKRA has secured backing from 1 investor. Prominent investors backing the company include Envision Pharma Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Compliant global publication planning is offered for life sciences. | 2001 | envisionpharmagroup.com | Fairfield, United States |
Investor details for OKRA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OKRA
7 people are tracked at OKRA (2 in leadership, 5 in team); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
Loubna Bouarfa | Founder & CEO | Leadership |
Xavier Jacquot | Talent Partner | Leadership |
Alessio Caciagli | Machine Learning Team Lead | Team |
Saeed Choobani | AI Developer | Team |
Ondřej Zacha | NLP Lead | Team |
Özge Özgüleryüz | Marketing Manager | Team |
Alberto Jauregui Dominguez | Full-stack Developer | Team |
Complete people profiles for OKRA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OKRA
3 dated milestones of OKRA across 7 years, from founding to its latest funding, stage changes and deals.
- Founded OKRA is founded.
- Funding First funding round of $4.2M.
- Exit Acquired by Envision Pharma Group.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Okra
Complete news archive for OKRA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OKRA
OKRA was founded in 2016 and raised its 1st funding round 2 years after it was founded.
OKRA is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Loubna Bouarfa is the CEO of OKRA, as recorded in our data. They have also founded this company.
OKRA is a funded company, having raised a total of $4.16M across 1 funding round to date. The company's 1st funding round was a Series A of $4.16M, raised on Mar 2018.
OKRA has 22 employees.
AI powered platform specializing in healthcare and life sciences. It integrates and analyzes complex datasets from internal, public, and third-party sources to deliver actionable, evidence-based insights and predictions in real time. The platform supports decision-making across the drug development and commercialization lifecycle, helping pharmaceutical and life sciences professionals optimize commercial, medical, and market access strategies.
OKRA offers AI Brain, Commercial Solutions, and Medical Intelligence.
OKRA has 1 investor. Key investors include Envision Pharma Group.
OKRA operates through Okra Technologies Limited.
Yes. OKRA was acquired by Envision Pharma Group in February 2023.